Remove Insulin Remove Licensing Remove Marketing Remove Pharma Companies
article thumbnail

Arecor hopes London stock market float will raise profile of insulin products

pharmaphorum

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. Arecor has four active licensing agreement in place with partners including Hikma and Inhibrx.

Insulin 52
article thumbnail

How the patient voice is becoming vital for drug approval

pharmaphorum

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Arecor heads for London Stock Exchange with drug reformulation strategy

pharmaphorum

Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed drugs reformulated to provide extra benefits for patients. .

Insulin 52
article thumbnail

A history of the pharmaceutical industry

pharmaphorum

Previously a centre of the trade in textiles and dyes, Swiss manufacturers gradually began to realise their dyestuffs had antiseptic and other properties and began to market them as pharmaceuticals, in contrast to the origin in pharmacies of other enterprises. An advert for Bayer’s Aspirin from the early 20th century.

Medicine 145
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52